Davidson Kahn Capital Management »

Immunitybio shares owned by Davidson Kahn Capital Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Davidson Kahn Capital Management from 13F filings

Historical chart of Davidson Kahn Capital Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Davidson Kahn Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Davidson Kahn Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4M 163k 8.76

More positions owned by Davidson Kahn Capital Management

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Amazon (AMZN)
Perimeter Solutions Common Stock (PRM)
Alphabet Cap Stk Cl A (GOOGL)
Wisdomtree Tr Us Midcap Fund (EZM)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Coupang Cl A (CPNG)
Floor & Decor Hldgs Cl A (FND)
Old Dominion Freight Line (ODFL)
Meta Platforms Cl A (META)

View all positions for Davidson Kahn Capital Management

Top funds holding Immunitybio

BlackRock
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
D. E. Shaw & Co
Two Sigma Investments
Geode Capital Management
Susquehanna International
Citadel Advisors
Millennium Management
LMR Partners
Morgan Stanley
Northern Trust
Goldman Sachs Group
UBS Group

View all funds holding Immunitybio